- Home
- KTTA vs VERO Comparison
KTTA vs VERO Comparison
Compare KTTA & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- VERO
- Stock Information
- Founded
- KTTA 2020
- VERO N/A
- Country
- KTTA United States
- VERO Canada
- Employees
- KTTA N/A
- VERO N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- VERO Medical/Dental Instruments
- Sector
- KTTA Health Care
- VERO Health Care
- Exchange
- KTTA Nasdaq
- VERO Nasdaq
- Market Cap
- KTTA 5.1M
- VERO 4.6M
- IPO Year
- KTTA 2021
- VERO N/A
- Fundamental
- Price
- KTTA $0.68
- VERO $2.46
- Analyst Decision
- KTTA
- VERO
- Analyst Count
- KTTA 0
- VERO 0
- Target Price
- KTTA N/A
- VERO N/A
- AVG Volume (30 Days)
- KTTA 119.6K
- VERO 45.8K
- Earning Date
- KTTA 08-19-2025
- VERO 08-14-2025
- Dividend Yield
- KTTA N/A
- VERO N/A
- EPS Growth
- KTTA N/A
- VERO N/A
- EPS
- KTTA N/A
- VERO N/A
- Revenue
- KTTA N/A
- VERO $60,997,000.00
- Revenue This Year
- KTTA N/A
- VERO N/A
- Revenue Next Year
- KTTA N/A
- VERO $7.47
- P/E Ratio
- KTTA N/A
- VERO N/A
- Revenue Growth
- KTTA N/A
- VERO N/A
- 52 Week Low
- KTTA $0.65
- VERO $2.10
- 52 Week High
- KTTA $7.50
- VERO $14.50
- Technical
- Relative Strength Index (RSI)
- KTTA 38.79
- VERO 47.18
- Support Level
- KTTA $0.67
- VERO $2.41
- Resistance Level
- KTTA $0.79
- VERO $2.77
- Average True Range (ATR)
- KTTA 0.04
- VERO 0.14
- MACD
- KTTA 0.00
- VERO -0.01
- Stochastic Oscillator
- KTTA 23.70
- VERO 21.88
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.